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http://dx.doi.org/10.1016/j.gmbhs.2Abstract The glutathione S-transferase mu (GSTM1) and theta (GSTT1) members of the GST
multigene family are polymorphic in human populations, and homozygous deletions or null
genotypes of GSTT1 and GSTM1 genes have been reported in different populations. Epidemio-
logical studies suggest that individuals who are homozygous null at the GSTM1 or GSTT1 loci
may have an increased risk of cancer; therefore, the distribution of these genotypes in the
human population is of great interest. The aim of our study was to investigate the allelic vari-
ations of GSTM1 and GSTT1 genotypes in 308 healthy, unrelated individuals from the state of
Haryana in India. The participants were genotyped for the presence of GSTM1 and GSTT1 genes
using the multiplex polymerase chain reaction (PCR) technique. On the basis of the results
from our findings, we found that, in the geographic region of our study (India), 40.58% of indi-
viduals are carriers of the GSTM1 0/0 (null) genotype, whereas 32.79% of individuals have the
GSTT1 0/0 (null) genotype. This study contributes significant information on the variability of
GSTT1 and GSTM1 gene polymorphisms in the worldwide population and could increase knowl-
edge about the relationship between ethnicity and the prevalence of certain diseases.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.t of Biotechnology, Kuruk-
na, India.
(A. Yadav).
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012.10.001Introduction
Epidemiological evidence indicates that most human
cancers are originally caused by environmental exposure to
genotoxic agents. In order to protect cells from DNA
damage by various forms of reactive substances, a cellular
system for detoxification has evolved. Glutathionerker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Allelic variation of GSTM1 and GSTT1 genes 99S-transferases (GSTs) comprise a complex multigenic family
of phase II metabolizing enzymes that are involved in the
conjugation reaction in phase II metabolism of xenobiotics,
catalyzing reactions between glutathione and a variety
of potentially toxic and carcinogenic electrophilic
compounds.1,2 GSTM1 (mu) and GSTT1 (theta) are the two
most studied isoenzymes of the GST family. The former
catalyzes the detoxification of genotoxins including
aromatic hydrocarbon epoxides and products of oxidative
stress such as DNA hydroperoxides,3 whereas the latter
utilizes constituents of cigarette smoke such as alkyl
halides.4 Polymorphism has been identified within three
alleles of GSTM1, i.e., GSTM1*0, GSTM1*A, and GSTM1*B.
GSTM1*0 is a null allele consisting of the complete deletion
of the GSTM1 gene. Individuals who are homozygous for this
allele are unable to produce the GSTM1 protein. The
frequency of the GSTM1 0/0 genotype (40e60%) varies
among ethnic groups.5e7 The gene GSTT1 belongs to the
theta class, located on chromosome 22.8 It is also poly-
morphic and presents two alleles, GSTT1*1 active allele and
the GSTT1*0 null gene. Like GSTM1, GSTT1*0 is a nonfunc-
tional allele resulting from the deletion of the GSTT1 gene,
with GSTT1 0/0 (or null) phenotype individuals being unable
to produce the GSTT1 protein.9 The homozygous GSTT1 null
phenotype has been described in different populations and
shows wide variations.10 GSTM1 and GSTT1 are potent
cancer susceptibility genes because they are prone to
induction by numerous known or suspected carcinogenic
compounds.11,12 Therefore, the knowledge about the exis-
tence of these susceptible genes in different ethnic groups
is very important for effective disease prevention espe-
cially against cancer. The aim of this study is to contribute
to knowledge of the frequencies of the GSTM1 and GSTT1
homozygous null genotypes. We have investigated these
genotypes in Haryana state, India. This is the first study of
its kind to have been carried out in the Haryana population.
Materials and methods
Studied population and sample collection
The study was carried out on a group of 308 unrelated
healthy individuals consisting of 199 males and 109 females,
aged 18e52 years. All participants, who were natives of
Haryana, were informed about the objectives of the study.
They were asked to sign an informed consent form, and
each participant was personally interviewed using a stan-
dard questionnaire, providing information related to their
socioeconomic status. The research protocol for the studyTable 1 Primer sequences for GSTM1 and GSTT1 genotypes.
Gene Primer sequence
GSTM1 Fw 50-GAACTCCCT
Re 50-GTTGGGGCT
GSTT1 Fw 50-TTCCTTACT
Re 50-TCACCG GAT
CYP1A1 (internal control) Fw 50-GAACTGCCA
Re 50-CAGCTGCATwas approved by the ethics committee of Kurukshetra
University, Kurukshetra (Haryana), India. A blood sample
(2 ml) was collected from each selected individual in
a vacutainer tube consisting of dipotassium ethylenedi-
amine tetraacetic acid for the extraction of DNA. The
samples were brought to the laboratory in a well-insulated
ice box.
GSTM1 and GSTT1 genotyping
Genomic DNA was isolated from 200 mL of whole blood by
using a Spin column kit (Bangalore genei, India). Multiplex
polymerase chain reaction (PCR) was used to detect the
presence or absence of GSTM1 and GSTT1 gene.13 Part of
exon 7 of the constitutional gene CYP1A1 was coamplified
as an internal control. The primer sequence and product
size of studied genes are given in Table 1 in accordance
with Abdel-Rahman et al.13 Amplification was carried out in
a 25-mL reaction mixture consisting of 1 mL genomic DNA
template (100 ng/mL), 1 mL of each primer (20 pmol/mL),
0.5 mL of dNTPs (200 mM), 2.5 mL PCR buffer with 15 mM/L
MgCl2 (1) and 0.5 mL Taq polymerase (3 U/mL). A total of
35 temperature cycles were carried out. PCR cycling
conditions were: 10 minutes at 94 C, 1 minute at 94 C, 30
seconds at 59 C, and 1 minute at 72 C. The last elongation
step was extended to 10 minutes at 72 C. The amplification
products were analyzed in 2% ethidium bromide agarose
gel.
Statistical analysis
The GSTM1 and GSTTI genotype frequencies were obtained
by direct counting, and their relationship with gender type
within the population was determined by Chi-square test
using statistical software (SPSS v.16.0; IBM, New York, NY,
USA).
Results
Table 2 shows the results for GSTM1 and GSTT1 genotyping
and the general frequency distributions of GST variants in
the study population. The homozygous null GSTM1*0 and
GSTT1*0 genotypes were found in 40.58% and 32.79%,
respectively. About 8.44% of the participants were found to
be homozygous for both GSTM1*0 and GSTT1*0. The distri-
bution of both genotypes (null and non-null) was not found
to be significantly different among male and female
participants (p > 0.05). The allelic distribution of GSTM1
and GSTT1 among different ethnic groups is shown inProduct size (bp)
GAAAAGCTAAGC-30 215
CAAATATACGGTGG-30
GGTCCTCACATCTC-30 480
CATGGCCAGCA-30
CTTCAGCTGTCT-30 312
TTGGAAGTGCTC-30
Table 2 Overall distributions of GSTM1 and GSTT1 genotypes according to gender in the Haryana population.
Genotype Numbers of individuals (%) Number of males (%) Number of females (%)
GSTM1
Null 125 (40.58) 78 (39.20) 47 (43.12)
Non-null 183 (59.42) 121 (60.80) 62 (56.88)
GSTT1
Null 101 (32.79) 65 (32.66) 36 (33.03)
Non-null 207 (67.21) 134 (67.34) 73 (66.97)
GSTM1 null and GSTT1 null 26 (8.44) 19 (9.55) 7 (6.42)
GSTM1 non-null and GSTT1 non-null 282 (91.56) 180 (90.45) 102 (93.58)
Chi-square test was used for comparison of gene frequency between male and female participants. No significant difference was
observed (p > 0.05).
100 A. Kumar et al.Table 3. The highest frequency of GSTM1 (57.3%) and GSTT1
(52%) null was observed in European and Asian populations,
respectively.Discussion
GSTs play a key role in detoxification processes in the body.
However, some pathways catalyzed by GST enzymes can
lead to more toxic products; therefore, expression of
GSTM1 and GSTT1 and exposure to certain substrates might
pose risks rather than advantages. The deleterious effects
as well as the advantages of GST polymorphism could
explain why nature maintains the null phenotypes in human
populations. The findings of our study show that frequen-
cies of the GSTM1 and GSTT1 null genotypes were relativelyTable 3 Worldwide distribution of GSTM1 and GSTT1 null geno
Reference Population Numbe
Autrup et al. 199923 Caucasian 441
Rebbeck et al. 199911 Caucasian 476
Nam et al. 200324 Caucasian 1031
Medeiros et al. 200425 Caucasian 335
Joseph et al. 200421 Caucasian 537
Murata et al. 200118 Asian 315
Nakazato et al. 200334 Asian 186
Komiya et al. 200519 Asian 484
Liu et al. 200920 Asian 1512
Mishra et al. 200417 Asian (Indian) 370
Roy et al. 200114 Asian (Indian) 299
Srivastava et al. 200516 Asian (Indian) 271
Present study Asian (Indian) 306
Yalin et al., 200728 European 196
Gubdacker et al. 200727 European 192
Buchard et al. 200726 European 200
Piacentini et al. 201129 European 493
Fujihara et al., 200933 African 341
Mallick et al. 200732 African 268
Piacentini et al. 201129 African 493
Buchard et al. 200726 African 200
Agalliu et al. 200631 African-American 752
Millikan et al. 200030 American 271
Millikan et al. 200030 American 392high in the Haryana population. Members of the GST family
are important candidates involved in cancer susceptibility
to commonly occurring forms of cancers because they may
regulate an individual’s susceptibility to metabolize
a carcinogen. Carriers of homozygous deletion in GSTM1
and GSTT1 genes have an absence of GST-m and GST-q
enzyme activity, respectively. These deletion variants are
very useful in epidemiological studies of cancer because
they divide individuals in two well-defined susceptibility
classes: those who are and those who are not able to
detoxify potential carcinogens by the metabolic pathways
regulated by GSTM1 and GSTT1 genes. We observed that
40.58% of the Haryana population were homozygous for the
GSTM1 deletion. This frequency is similar to the result of
a previous study among Indians, where GSTM1 null
frequency has been reported to vary between 20.0% andtypes.
r of individuals GSTM1 null (%) GSTT1 null (%)
53.5 15.3
47.6 31.2
48.5 23.2
49.2 23.9
53.6 23.0
42.5 52.0
50.5 41.9
54.5 48.3
52.0 38.7
33.0 18.4
20e79 3e39
35.4 20.1
40.6 32.8
32.7 22.4
57.3 17.5
52.5 14.0
49.2 28.2
11.2 35.8
26.9 36.6
43.8 37.3
40.0 44.0
46.7 26.7
28.0 17.0
52.0 16.0
Allelic variation of GSTM1 and GSTT1 genes 10179.0%.14,15 We observed that the GSTT1 gene is lacking in
about 32.79% of the Haryana population. Contradictory to
our results, in other studies, 20.10% and 18.4% frequency of
the GSTT1 null genotype was observed in other Indian
populations.16,17 Among other Asian populations, variations
have been observed for the null genotype of both GSTM1
(42.5%, 54.5%, and 52.0%) and GSTT1 (52.0%, 48.3%, and
38.7%) genes, respectively.18e20 The frequencies were
higher than those observed in our findings. Our results for
GSTM1 null genotype are in agreement with the findings of
some studies.21,22 Among Caucasian populations, the
researchers have reported that the frequency of GSTM1 null
varies between 13.1% and 53.6%, and for GSTT1 null, it
varies between 10.9% and 31.2%.23e25 Among Europeans,
GSTM1 and GSTT1 null frequency varies from 32.7% to 49.2%
and 22.4% to 28.2%, respectively.26e29 Similarly, among
African populations, GSTM1 null frequencies vary from
11.2% to 40.0%, and GSTT1 null varies from 35.8% to
44.0%.30e33
Such variations in the Haryana population in contrast to
the rest of the world population signify the impact of
ethnicity. Thus, this kind of study may form the basis for
future establishment of epidemiological and clinical
databases. This approach also has the potential for identi-
fying susceptible individuals. We believe that further
investigation of GSTM1 and GSTT1 allelic variants in Indian
populations will provide useful information for the identi-
fication of founder mutations and ethnic predisposition
alleles that result in various cancerous disease phenotypes.
Conclusions
The present study regarding genotyping of GSTM1 and
GSTT1 genes in the Haryana population is an important
contribution to future biomonitoring studies that aim to
assess risk from exposure to xenobiotics. This study
contributes significant information on the variability of
GSTT1 and GSTM1 gene polymorphisms in the worldwide
population and could increase knowledge about the rela-
tionship between ethnicity and the prevalence of certain
diseases. It may prove useful for national epidemiological
studies for effective disease prevention, especially against
cancer.
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